Literature DB >> 7827774

Studies on small (< 300 microns) microcapsules: II--Parameters governing the production of alginate beads by high voltage electrostatic pulses.

J P Hallé1, F A Leblond, J F Pariseau, P Jutras, M J Brabant, Y Lepage.   

Abstract

The size of microcapsules is a critical parameter in the immunoisolation of islets of Langerhans by microencapsulation. The use of smaller capsules decreases the total implant volume and improves insulin kinetics and oxygen supply. A high voltage electrostatic pulse system was used for the production of small (< 300 microns) alginate beads, the first step of the encapsulation technique. However, islets often protruded from capsules that were too small, further emphasizing the need for a method to control bead size. A study of 7 parameters [electrostatic pulse amplitude (A), duration (D) and wavelength (lambda), pump flow rate (P), needle gauge, alginate viscosity and distance between electrodes] showed that P (r = 0.981, p = 0.003) and lambda (r = 0.988, p = 0.0002) were the principal determinants of bead size. To detect potential interactions between parameters, 270 combinations of different levels of A, D, lambda, and P were studied. A multivariate regression analysis of these data confirmed that P and lambda are the prime determinants of bead size, and showed that a 2-parameter (P, lambda) model could be used to precisely predict bead size (R2 = 0.84), while keeping the application simple. The precision of the predictive model is only slightly improved by the use of additional parameters. The reliability of the data used to elaborate this model was demonstrated (p = 0.6226) by comparing them with a second data set obtained under the same conditions. A third set of experiments confirmed the applicability of the model. This work has major implications on the preclinical application of microencapsulation since it showed that it is possible to predetermine the bead size.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827774     DOI: 10.1177/096368979400300503

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  10 in total

Review 1.  Enhancing clinical islet transplantation through tissue engineering strategies.

Authors:  Jaime A Giraldo; Jessica D Weaver; Cherie L Stabler
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

Review 2.  Bioengineered stem cells as an alternative for islet cell transplantation.

Authors:  Sarah J Moore; Boris L Gala-Lopez; Andrew R Pepper; Rena L Pawlick; Am James Shapiro
Journal:  World J Transplant       Date:  2015-03-24

3.  The prospect of induced pluripotent stem cells for diabetes mellitus treatment.

Authors:  Andreas Soejitno; Pande Kadek Aditya Prayudi
Journal:  Ther Adv Endocrinol Metab       Date:  2011-10       Impact factor: 3.565

4.  Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist.

Authors:  Barbara Ludwig; Avi Rotem; Janine Schmid; Gordon C Weir; Clark K Colton; Mathias D Brendel; Tova Neufeld; Norman L Block; Karina Yavriyants; Anja Steffen; Stefan Ludwig; Triantafyllos Chavakis; Andreas Reichel; Dimitri Azarov; Baruch Zimermann; Shiri Maimon; Mariya Balyura; Tania Rozenshtein; Noa Shabtay; Pnina Vardi; Konstantin Bloch; Paul de Vos; Andrew V Schally; Stefan R Bornstein; Uriel Barkai
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-05       Impact factor: 11.205

Review 5.  Islet Microencapsulation: Strategies and Clinical Status in Diabetes.

Authors:  Mustafa Omami; James J McGarrigle; Mick Reedy; Douglas Isa; Sofia Ghani; Enza Marchese; Matthew A Bochenek; Maha Longi; Yuan Xing; Ira Joshi; Yong Wang; José Oberholzer
Journal:  Curr Diab Rep       Date:  2017-07       Impact factor: 4.810

6.  Functional improvement of porcine neonatal pancreatic cell clusters via conformal encapsulation using an air-driven encapsulator.

Authors:  Sol Ji Park; Soojeong Shin; Ok Jae Koo; Joon Ho Moon; Goo Jang; Curie Ahn; Byeong Chun Lee; Young Je Yoo
Journal:  Exp Mol Med       Date:  2012-01-31       Impact factor: 8.718

Review 7.  Alginate: Enhancement Strategies for Advanced Applications.

Authors:  Alejandro Hurtado; Alaa A A Aljabali; Vijay Mishra; Murtaza M Tambuwala; Ángel Serrano-Aroca
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

8.  Glucose-stimulated insulin release: Parallel perifusion studies of free and hydrogel encapsulated human pancreatic islets.

Authors:  Peter Buchwald; Alejandro Tamayo-Garcia; Vita Manzoli; Alice A Tomei; Cherie L Stabler
Journal:  Biotechnol Bioeng       Date:  2017-09-19       Impact factor: 4.530

Review 9.  Immunoisolation: where regenerative medicine meets solid organ transplantation.

Authors:  Rajesh Pareta; Brian Sanders; Paurush Babbar; Tom Soker; Christopher Booth; John McQuilling; Sittadjody Sivanandane; Robert J Stratta; Giuseppe Orlando; Emmanuel C Opara
Journal:  Expert Rev Clin Immunol       Date:  2012-09       Impact factor: 4.473

Review 10.  Integration of nano- and biotechnology for beta-cell and islet transplantation in type-1 diabetes treatment.

Authors:  Andras Dinnyes; Andrea Schnur; Suchitra Muenthaisong; Peter Bartenstein; Charles-Thibault Burcez; Neal Burton; Clemens Cyran; Pierre Gianello; Elisabeth Kemter; Gabor Nemeth; Francesco Nicotra; Eszter Prepost; Yi Qiu; Laura Russo; Andras Wirth; Eckhard Wolf; Sibylle Ziegler; Julianna Kobolak
Journal:  Cell Prolif       Date:  2020-04-27       Impact factor: 6.831

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.